{"schema_version":"1.0","type":"article","title":"GSK's US$10.6 Billion Nuvalent Deal Is Really a Bet on Resistance and Brain Metastases","url":"https://drugnews.com.tw/articles/2026-06-19-gsk-nuvalent-lung-cancer-resistance-brain-metastasis-en.html","markdown_url":"https://drugnews.com.tw/articles/2026-06-19-gsk-nuvalent-lung-cancer-resistance-brain-metastasis-en.md","lang":"en","date":"2026-06-19","publish_at":"2026-06-19T08:00:00+08:00","updated_at":"2026-06-19","category":"商業分析系列","topic":"商業分析系列","tags":["GSK","Nuvalent","Lung cancer","Precision oncology","Resistance","Brain metastases"],"summary":"GSK is not merely buying three lung-cancer pipelines. It is buying a next-generation precision-oncology strategy around resistance, CNS activity, and cleaner kinase inhibition.","key_points":[],"facts":[],"sections":[],"references":[],"images":[{"alt":"What GSK bought","url":"https://drugnews.com.tw/assets/articles/gsk-nuvalent-lung-cancer-resistance-brain-metastasis-en/figure-01.png"},{"alt":"Precision oncology moat","url":"https://drugnews.com.tw/assets/articles/gsk-nuvalent-lung-cancer-resistance-brain-metastasis-en/figure-02.png"},{"alt":"BD logic","url":"https://drugnews.com.tw/assets/articles/gsk-nuvalent-lung-cancer-resistance-brain-metastasis-en/figure-03.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/gsk-nuvalent-lung-cancer-resistance-brain-metastasis-en/cover.png","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-06-19）。GSK's US$10.6 Billion Nuvalent Deal Is Really a Bet on Resistance and Brain Metastases。https://drugnews.com.tw/articles/2026-06-19-gsk-nuvalent-lung-cancer-resistance-brain-metastasis-en.html","disclaimer":"This article is intended for industry research and knowledge sharing only. It does not constitute investment, medical, fundraising, or individual stock advice.","translations":{"zh-Hant":"2026-06-19-gsk-nuvalent-lung-cancer-resistance-brain-metastasis.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}